MEIS2 and ovarian carcinoma: For example, Meis2 has been revealed to be overexpressed in ovarian cancer and inhibit the proliferation and tumorigenicity of ovarian cancer cells, which was connected to improving the prognosis for patient with ovarian cancer [50].